Cargando…

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

MHC-I presents tumor antigens to CD8(+) T cells and triggers anti-tumor immunity. Humans may have 30,000-60,000 long noncoding RNAs (lncRNAs). However, it remains poorly understood whether lncRNAs may affect tumor immunity. Here, we identify a LncRNA, capable of Inducing MHC-I and Immunogenicity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Gaopeng, Kryczek, Ilona, Nam, Jutaek, Li, Xiong, Li, Shasha, Li, Jing, Wei, Shuang, Grove, Sara, Vatan, Linda, Zhou, Jiajia, Du, Wan, Lin, Heng, Wang, Ton, Subramanian, Chitra, Moon, James J., Cieslik, Marcin, Cohen, Mark, Zou, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122078/ https://www.ncbi.nlm.nih.gov/pubmed/33958760 http://dx.doi.org/10.1038/s41556-021-00672-3

Ejemplares similares

Metabolism drives macrophage heterogeneity in the tumor microenvironment
por: Li, Shasha, et al.
Publicado: (2022)

The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated anti-tumor immunity
por: Zhou, Jiajia, et al.
Publicado: (2021)

CD8(+) T cells regulate tumor ferroptosis during cancer immunotherapy
por: Wang, Weimin, et al.
Publicado: (2019)

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis
por: Xia, Houjun, et al.
Publicado: (2020)

DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway
por: Sun, Danfeng, et al.
Publicado: (2022)

Th17 cells have stem cell-like features and promote long-term immunity
por: Wei, Shuang, et al.
Publicado: (2012)

Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
por: Zhao, Ende, et al.
Publicado: (2012)

Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy
por: Peng, Dongjun, et al.
Publicado: (2015)

LncRNA and its role in gastric cancer immunotherapy
por: Zhang, Qiang, et al.
Publicado: (2023)

LncRNA FENDRR Expression Correlates with Tumor Immunogenicity
por: Munteanu, Maria Cristina, et al.
Publicado: (2021)

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation
por: Bian, Yingjie, et al.
Publicado: (2020)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

LncRNA-Mediated Adipogenesis in Different Adipocytes
por: Zhang, Peiwen, et al.
Publicado: (2022)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer
por: Cai, Yi, et al.
Publicado: (2020)

lncRNAfunc: a knowledgebase of lncRNA function in human cancer
por: Yang, Mengyuan, et al.
Publicado: (2021)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Li, Fulei, et al.
Publicado: (2023)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns
por: Li, Yongsheng, et al.
Publicado: (2015)

Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers
por: Shao, Tingting, et al.
Publicado: (2022)

Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme
por: Zhang, Binbin, et al.
Publicado: (2022)

Regulation of lncRNA expression
por: Wu, Zhuomin, et al.
Publicado: (2014)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Construction of lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA biomarkers in glioblastomas
por: Zan, Xiang-Yang, et al.
Publicado: (2019)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

Knockdown of lncRNA ZNRD1‐AS1 inhibits progression of bladder cancer by regulating miR‐194 and ZEB1
por: Gao, Zhixiang, et al.
Publicado: (2020)

Nanocarriers for cancer nano-immunotherapy
por: Rana, Isra, et al.
Publicado: (2022)

The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis
por: Pinkney, Holly R., et al.
Publicado: (2020)

LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3
por: Liu, Yingnan, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells
por: Mao, Zhengqiang, et al.
Publicado: (2017)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vejla86erhrsg94q5ldtr0ehnv